Cardiology

Vitamin D status is linked to the reduction of chronic diseases through gene expression, according to a new study.

Takeda Canada is introducing a new angiotensin II blocker (ARB) for the treatment of hypertension.

Check out our review of recent medical stories in the media - Top Story: Personalized prescriptions reduce side effects, increase efficiency. Read this and

Your patients need to know that taking advantage of tax credits can go a long way to making things easier for low-income Canadians, both in health and finances

Forest Laboratories will soon launch a new once-daily beta-blocker for the treatment of mild to moderate essential hypertension.

OTTAWA | Canadians with debilitating diseases will soon benefit from new personalized approaches to treatment thanks to Canadian research and government funding.

Check out our review of recent stories in the media - Top Story: Hospital parking rates a 'tax' on sick Canadians. Read this and